Shanghai No1 Pharmacy Co Ltd (600833) — Tangible Net Worth Ratio

Latest as of March 2026: 97.0%

Shanghai No1 Pharmacy Co Ltd (600833) has a Tangible Net Worth Ratio of 97.0% as of March 2026. This metric is calculated by deducting intangible assets (CN¥35.86 Million) from net assets (CN¥1.19 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See Shanghai No1 Pharmacy Co Ltd (600833) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.

Tangible NW Ratio

97.0%
Tangible equity / total equity

Net Assets (Equity)

CN¥1.19 Billion
CNY

Intangible Assets

CN¥35.86 Million
Goodwill, patents, brand value

Total Assets

CN¥1.99 Billion
CNY

Shanghai No1 Pharmacy Co Ltd Tangible Net Worth Ratio (1994–2025)

This chart shows how Shanghai No1 Pharmacy Co Ltd's Tangible Net Worth Ratio has changed across 30 annual periods from 1994 to 2025. As of March 2026, the ratio stands at 97.0%, reflecting net assets of CN¥1.19 Billion with intangible assets of CN¥35.86 Million CNY. See Shanghai No1 Pharmacy Co Ltd (600833) liquidity interval to measure how many days the company can operate on defensive assets alone.

Annual Tangible Net Worth Ratio for Shanghai No1 Pharmacy Co Ltd (1994–2025)

The table below presents the year-by-year Tangible Net Worth Ratio for Shanghai No1 Pharmacy Co Ltd from 1994 to 2025, covering 30 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see 600833 market cap overview.

Year Tangible NW Ratio Net Assets (CNY) Intangible Assets Total Assets Change (pp)
2025 96.9% CN¥1.17 Billion CN¥36.46 Million CN¥2.02 Billion ▲ +0.3 pp
2024 96.6% CN¥1.14 Billion CN¥38.93 Million CN¥1.98 Billion ▲ +0.7 pp
2023 95.9% CN¥1.01 Billion CN¥41.67 Million CN¥1.86 Billion ▲ +0.4 pp
2022 95.4% CN¥958.68 Million CN¥43.83 Million CN¥2.04 Billion ▲ +1.4 pp
2021 94.0% CN¥777.92 Million CN¥46.33 Million CN¥1.33 Billion ▲ +0.5 pp
2020 93.6% CN¥749.32 Million CN¥48.19 Million CN¥1.40 Billion ▲ +0.5 pp
2019 93.1% CN¥732.34 Million CN¥50.79 Million CN¥1.22 Billion ▲ +1.1 pp
2018 92.0% CN¥669.57 Million CN¥53.68 Million CN¥1.08 Billion ▼ 0.0 pp
2017 92.0% CN¥714.07 Million CN¥57.20 Million CN¥1.14 Billion ▲ +0.1 pp
2016 91.9% CN¥736.00 Million CN¥59.82 Million CN¥1.19 Billion ▼ -0.5 pp
2015 92.4% CN¥783.09 Million CN¥59.40 Million CN¥1.23 Billion ▲ +1.9 pp
2014 90.5% CN¥650.97 Million CN¥61.98 Million CN¥1.08 Billion ▲ +3.1 pp
2013 87.4% CN¥536.14 Million CN¥67.51 Million CN¥916.16 Million ▲ +1.4 pp
2012 86.0% CN¥499.84 Million CN¥70.12 Million CN¥892.27 Million ▲ +3.0 pp
2011 83.0% CN¥429.41 Million CN¥73.00 Million CN¥794.21 Million ▲ +0.3 pp
2010 82.7% CN¥435.88 Million CN¥75.35 Million CN¥788.18 Million ▲ +1.1 pp
2009 81.7% CN¥402.25 Million CN¥73.81 Million CN¥721.57 Million ▲ +5.9 pp
2008 75.7% CN¥314.16 Million CN¥76.20 Million CN¥589.11 Million ▼ -4.6 pp
2007 80.3% CN¥393.54 Million CN¥77.53 Million CN¥696.57 Million ▲ +13.4 pp
2006 66.9% CN¥245.77 Million CN¥81.28 Million CN¥481.15 Million ▼ -32.7 pp
2005 99.6% CN¥232.68 Million CN¥839.98K CN¥343.66 Million ▲ +1.1 pp
2004 98.5% CN¥202.62 Million CN¥2.98 Million CN¥429.02 Million ▲ +0.3 pp
2003 98.3% CN¥189.49 Million CN¥3.28 Million CN¥485.08 Million ▲ +0.1 pp
2002 98.2% CN¥176.31 Million CN¥3.15 Million CN¥478.39 Million ▲ +0.1 pp
2001 98.1% CN¥165.52 Million CN¥3.14 Million CN¥482.76 Million ▼ -1.9 pp
1998 100.0% CN¥99.97 Million CN¥0.00 CN¥986.83 Million ▲ +0.0 pp
1997 100.0% CN¥345.33 Million CN¥0.00 CN¥1.18 Billion ▲ +1.4 pp
1996 98.6% CN¥305.33 Million CN¥4.42 Million CN¥1.38 Billion ▼ -0.3 pp
1995 98.9% CN¥287.59 Million CN¥3.25 Million CN¥1.22 Billion ▼ -1.1 pp
1994 100.0% CN¥186.74 Million CN¥0.00 CN¥723.83 Million
pp = percentage points